Equities

United Therapeutics Corp

United Therapeutics Corp

Actions
  • Price (EUR)380.80
  • Today's Change3.20 / 0.85%
  • Shares traded4.00
  • 1 Year change+81.77%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,3281,9361,686
OPERATING EXPENSES
Cost of revenue total258152123
Selling, general and admin. expenses, total474471465
Depreciation/amortization------
Unusual expense(income)3.6013135
Other operating expenses, total------
Total operating expense1,1439581,132
Operating income1,185978554
Other, net1.80(4.3)(8.6)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,274951594
Provision for income taxes290223118
Net income after taxes985727476
Minority interest------
Net income before extra. Items985727476
Total extraordinary items------
Net income985727476
Inc.avail. to common excl. extra. Items985727476
Inc.avail. to common incl. extra. Items985727476
EPS RECONCILIATION
Basic/primary weighted average shares474645
Basic/primary eps excl. extra items211611
Basic/primary eps incl. extra items211611
Dilution adjustment------
Diluted weighted average shares504947
Diluted eps excl. extra items201510
Diluted eps incl. extra items201510
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental593219
SUPPLEMENTAL INCOME
Depreciation, supplemental535150
Total special items3.6013135
NORMALISED INCOME
Normalized income before taxes1,278964729
Effect of special items on income taxes0.823.034.28
Income tax excluding impact of special items290226122
Normalized income after tax988737606
Normalized income avail. to common988737606
Basic normalized EPS211614
Diluted normalized EPS201513
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.